NASA’s 35th Commercial Resupply Services (CRS‑35) mission will launch a suite of health‑focused experiments to the International Space Station. The payload, launched from Cape Canaveral Space Force Station in Florida, includes studies on human and plant biology as well as investigations into drug‑resistant organisms. The experiments are designed to assess how microgravity and spaceflight conditions influence cellular processes, disease progression, and microbial resistance.
SpaceX’s Falcon 9 rocket will deliver the cargo to the ISS, where the research will be conducted in the station’s laboratories. The data gathered will help scientists understand how space environments affect biological systems, informing both long‑duration human spaceflight and terrestrial medical applications. By studying plant growth and pathogen behavior in orbit, the mission also seeks to improve life‑support systems for future missions and enhance crop resilience on Earth.
Why it matters: The mission’s findings will advance knowledge of health risks in space and support the development of countermeasures for astronauts, while also providing insights that could improve disease treatment and agricultural productivity on Earth.
Written by AI from the linked reports below — original text, not copied from any source. Informational only, not investment advice; verify against the originals.